Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Oncotarget
|
November 28, 2014
Role of p53 in the progression of gastric cancer
Rita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Plant Biology (Stuttgart, Germany)
|
April 23, 2008
Effects of overexpression of endogenous phenylalanine ammonia-lyase (PALrs1) on accumulation of salidroside in Rhodiola sachalinensis
L-Q Ma, D-Y Gao, Y-N Wang, et al.
The Laryngoscope
|
April 18, 2019
Does drug-induced sleep endoscopy affect surgical outcome? A multicenter study of 326 obstructive sleep apnea patients
Kenny P Pang, Peter M Baptista, Ewa Olszewska, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
July 19, 2012
The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases
B Pang, M Dettmer, D Matthias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial
Jonathan G Hiller, Steven W Cole, Elizabeth M Crone, et al.
Oncotarget
|
November 16, 2017
LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness
Jia-Min B Pang, Ramyar Molania, Ashwini Chand, et al.
BMC Medical Genomics
|
June 3, 2014
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Stephen Q Wong, Jason Li, Angela Y-C Tan, et al.
Science Translational Medicine
|
June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancer
Emma Nolan, Peter Savas, Antonia N Policheni, et al.
The Journal of Pathology
|
January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53
Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Cell Death & Disease
|
July 17, 2015
Targeting Mdmx to treat breast cancers with wild-type p53
S Haupt, D Buckley, J-M B Pang, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Oncotarget
|
November 28, 2014
Role of p53 in the progression of gastric cancer
Rita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Plant Biology (Stuttgart, Germany)
|
April 23, 2008
Effects of overexpression of endogenous phenylalanine ammonia-lyase (PALrs1) on accumulation of salidroside in Rhodiola sachalinensis
L-Q Ma, D-Y Gao, Y-N Wang, et al.
The Laryngoscope
|
April 18, 2019
Does drug-induced sleep endoscopy affect surgical outcome? A multicenter study of 326 obstructive sleep apnea patients
Kenny P Pang, Peter M Baptista, Ewa Olszewska, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
July 19, 2012
The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases
B Pang, M Dettmer, D Matthias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial
Jonathan G Hiller, Steven W Cole, Elizabeth M Crone, et al.
Oncotarget
|
November 16, 2017
LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness
Jia-Min B Pang, Ramyar Molania, Ashwini Chand, et al.
BMC Medical Genomics
|
June 3, 2014
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Stephen Q Wong, Jason Li, Angela Y-C Tan, et al.
Science Translational Medicine
|
June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancer
Emma Nolan, Peter Savas, Antonia N Policheni, et al.
The Journal of Pathology
|
January 19, 2017
MDM4 is a rational target for treating breast cancers with mutant p53
Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, et al.
Cell Death & Disease
|
July 17, 2015
Targeting Mdmx to treat breast cancers with wild-type p53
S Haupt, D Buckley, J-M B Pang, et al.
Page
of 14